Avvio Enhanced Lithotripsy System (ELS)

About Avvio Medical

Avvio Medical is pioneering a novel approach to kidney stone lithotripsy that could significantly disrupt the urology market. Their Enhanced Lithotripsy System (ELS) leverages low-pressure ultrasound and targeted microbubbles to perform stone comminution in an outpatient setting, eliminating the risks and costs associated with general anesthesia and ureteral stents. The company has achieved key regulatory and reimbursement milestones, including FDA Breakthrough Device Designation and a new CPT code, positioning it for clinical advancement and future commercialization. Founded in 2016 and based in San Diego, Avvio is a private company targeting a large and growing patient population burdened by current invasive procedures.

Therapeutic Areas